Who really benefits from the Quintis Ltd shareholder class action?

Some high profile class actions against large ASX listed companies are presently in progress, but should you join and will you benefit as a shareholder?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There have been some high profile class actions on behalf of shareholders against ASX companies recently including Commonwealth Bank of Australia (ASX: CBA), Dick Smith and Quintis Ltd (ASX: QIN), but is this practice beneficial for share investors?

Under a class action, a small "class" of shareholders seek to extract money from the company – at the expense of all current shareholders.

These class actions are bankrolled by litigation funders (legal funding) and in CBA's case the litigation funder is IMF Bentham Ltd (ASX: IMF).

While there may be some wrongdoing by the company, this type of class action, in the long run, will only work against the interests of current share investors.

More than likely the class action will simply run up large legal costs for both sides. For the Quintis Ltd class action (Bannister Law and legal funding from JustKapital), the fees are approximately 40% of any return.

The lawyers will get richer and the shareholders will get poorer. Even if the claim is successful, the shareholders named in the class action will likely see little or no proceeds after legal fees and compensation to the litigation funder.

Whatever the rights or wrongs of the company you can choose to accept your losses rather than encourage a litigation industry that can only enrich lawyers at the expense of shareholders, with additional compliance and other legal costs that threaten the value of all your other current and future share investments.

In my opinion the job of ensuring a fair playing field for shareholders by setting listing standards and other regulatory rules is for the ASX and ASIC, not for class actions and other expensive legal actions where the primary motive is to extract money from companies (i.e. shareholders) to earn legal fees and profits for litigation funders.

Motley Fool contributor Christopher Coe  owns shares in QIN. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »